Skip to main content

Table 1 Demographic and clinical characteristics of adolescents involved in the study

From: Impairment of microcirculation and vascular responsiveness in adolescents with primary Raynaud phenomenon

  Healthy Raynaud without current symptoms Raynaud with current symptoms
Number 25 15 12
Age (years) 16.5 ± 0.2 (14.8–19) 16.6 ± 0.4 (13.2–18.2) 16.2 ± 0.4 (13–18)
Duration of the disease (months) 23.2 ± 4.9 (2.4–54) 38.4 ± 6.9 (12–96)
Body fat composition (%) 24.0 ± 1.5 (4.3–41.8) 32.1 ± 2.7 (17.8–50.6)** 18.1 ± 1.7 (8.2–27.4)*, ###
Body Mass Index (BMI) 22.0 ± 0.8 (17.3–35.1) 25.8 ± 1.9 (17.6–39.5) 18.78 ± 0.4 (15.8–20.8) *, ##
Mean arterial blood pressure (mmHg) 87.5 ± 1.7 (73.3–107.0) 90.1 ± 1.6 (82–101.3) 81.7 ± 2.1 (71.7–97.0)*, #
  1. Data represent the means±SEM, as well as the range of the data in each group (*p < 0.05, ** p < 0.01 vs. healthy; #p < 0.05, ##p<0.01, ###p < 0.001 vs. patients without current symptoms, Kruskal-Wallis test followed by Dunn’s multiple comparison test for body mass index values, one-way ANOVA followed by Neuman-Keuls multiple comparison test for all other parameters)